IL127408A - History 2, 4 - Thiazolidinedione, process for their preparation and pharmaceutical preparations containing them - Google Patents

History 2, 4 - Thiazolidinedione, process for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL127408A
IL127408A IL12740897A IL12740897A IL127408A IL 127408 A IL127408 A IL 127408A IL 12740897 A IL12740897 A IL 12740897A IL 12740897 A IL12740897 A IL 12740897A IL 127408 A IL127408 A IL 127408A
Authority
IL
Israel
Prior art keywords
general formula
group
thiazolidinedione
compound
compounds
Prior art date
Application number
IL12740897A
Other languages
English (en)
Hebrew (he)
Other versions
IL127408A0 (en
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL127408A0 publication Critical patent/IL127408A0/xx
Publication of IL127408A publication Critical patent/IL127408A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12740897A 1996-06-07 1997-06-02 History 2, 4 - Thiazolidinedione, process for their preparation and pharmaceutical preparations containing them IL127408A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607070A FR2749583B1 (fr) 1996-06-07 1996-06-07 Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
PCT/EP1997/002851 WO1997047612A1 (fr) 1996-06-07 1997-06-02 Nouveaux derives de thiazolidine-2,4-dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Publications (2)

Publication Number Publication Date
IL127408A0 IL127408A0 (en) 1999-10-28
IL127408A true IL127408A (en) 2002-08-14

Family

ID=9492815

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12740897A IL127408A (en) 1996-06-07 1997-06-02 History 2, 4 - Thiazolidinedione, process for their preparation and pharmaceutical preparations containing them

Country Status (31)

Country Link
US (2) US6437143B2 (cs)
EP (1) EP0918759B1 (cs)
JP (2) JP3067809B2 (cs)
KR (1) KR20000016412A (cs)
CN (2) CN1075811C (cs)
AR (1) AR008387A1 (cs)
AT (1) ATE222897T1 (cs)
AU (1) AU726549B2 (cs)
BR (1) BR9709654A (cs)
CA (1) CA2257275A1 (cs)
CZ (1) CZ397598A3 (cs)
DE (1) DE69715009T2 (cs)
DK (1) DK0918759T3 (cs)
EE (1) EE04015B1 (cs)
ES (1) ES2180995T3 (cs)
FR (1) FR2749583B1 (cs)
HK (1) HK1019601A1 (cs)
HU (1) HUP0001744A3 (cs)
ID (1) ID17810A (cs)
IL (1) IL127408A (cs)
NO (1) NO312100B1 (cs)
NZ (1) NZ333645A (cs)
PL (1) PL330363A1 (cs)
PT (1) PT918759E (cs)
RU (1) RU2169144C2 (cs)
SK (1) SK164598A3 (cs)
TR (1) TR199802518T2 (cs)
TW (1) TW400330B (cs)
UA (1) UA57024C2 (cs)
WO (1) WO1997047612A1 (cs)
ZA (1) ZA974984B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
CA2344913A1 (en) * 1998-09-21 2000-03-30 University Of Florida Research Foundation, Inc. Antimalarial agents
CN1350526A (zh) * 1999-03-18 2002-05-22 小野药品工业株式会社 噻唑烷衍生物的制备方法
DK1206457T3 (da) 1999-08-27 2004-02-16 Lilly Co Eli Biaryl-oxa(thia)zolderivater og deres anvendelse som modulatorer PPAP'ER
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
FR2822069B1 (fr) * 2001-03-19 2003-06-20 Lipha Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete
FR2826278B1 (fr) * 2001-06-20 2005-03-25 Lipha Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
CN100516020C (zh) * 2001-09-26 2009-07-22 艾米斯菲尔技术有限公司 通过二羧化物中间体制备苯氧基链烷酸、链烯酸和炔酸及其盐的方法
FR2838968A1 (fr) * 2002-04-30 2003-10-31 Lipha Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete
FR2845003A1 (fr) * 2002-09-30 2004-04-02 Merck Sante Sas Utilisation de derives de thiazolidinedione comme inhibiteurs de l'aldose reductase
AU2003270473A1 (en) * 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
US20060263453A1 (en) * 2004-11-01 2006-11-23 Thomas Smith Methods and compositions for modulating glutamate dehydrogenase
DK3190106T3 (da) 2005-04-04 2019-07-15 Univ Florida Desferrithiocinpolyether-analoger
NZ579994A (en) * 2007-03-15 2011-09-30 Univ Florida Desferrithiocin polyether analogues useful in the treatment of pathological conditions responsive to chelation or sequestration of trivalent metal
ES2830073T3 (es) * 2007-04-11 2021-06-02 Omeros Corp Composiciones y métodos para la profilaxis y el tratamiento de adicciones
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US20160331729A9 (en) * 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
DE102007028925A1 (de) * 2007-06-22 2008-12-24 Saltigo Gmbh Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden
BR112014014544A2 (pt) 2011-12-16 2017-06-13 Univ Florida usos de análogos de 4'-desferritiocina
US9815777B2 (en) 2013-09-22 2017-11-14 Jiva Pharma, Inc. Metformin salts to treat Type2 diabetes
CA2930966A1 (en) 2013-11-22 2015-05-28 University Of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
CN107708693A (zh) 2015-04-27 2018-02-16 佛罗里达大学研究基金会 代谢程序化的金属螯合剂及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
TW268952B (cs) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
US5614544A (en) * 1993-09-14 1997-03-25 Takeda Chemical Industries, Ltd. Oxazolidinedione derivatives and their use
EP0783496B9 (en) * 1994-08-10 2003-09-03 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, their production and use

Also Published As

Publication number Publication date
US20010007875A1 (en) 2001-07-12
EP0918759B1 (fr) 2002-08-28
DE69715009D1 (de) 2002-10-02
HK1019601A1 (en) 2000-02-18
CA2257275A1 (en) 1997-12-18
ID17810A (id) 1998-01-29
CN1221410A (zh) 1999-06-30
JP3067809B2 (ja) 2000-07-24
AU3031797A (en) 1998-01-07
IL127408A0 (en) 1999-10-28
BR9709654A (pt) 1999-08-10
UA57024C2 (uk) 2003-06-16
ZA974984B (en) 1997-12-30
NO312100B1 (no) 2002-03-18
EE9800426A (et) 1999-06-15
PL330363A1 (en) 1999-05-10
JP2000226379A (ja) 2000-08-15
AR008387A1 (es) 2000-01-19
JP2000507270A (ja) 2000-06-13
ATE222897T1 (de) 2002-09-15
AU726549B2 (en) 2000-11-09
HUP0001744A3 (en) 2002-09-30
CN1075811C (zh) 2001-12-05
US20030100587A1 (en) 2003-05-29
NO985671L (no) 1998-12-04
KR20000016412A (ko) 2000-03-25
NZ333645A (en) 2000-05-26
NO985671D0 (no) 1998-12-04
TW400330B (en) 2000-08-01
FR2749583B1 (fr) 1998-08-21
RU2169144C2 (ru) 2001-06-20
EE04015B1 (et) 2003-04-15
US6437143B2 (en) 2002-08-20
TR199802518T2 (xx) 1999-04-21
CN1341588A (zh) 2002-03-27
HUP0001744A1 (hu) 2000-11-28
CZ397598A3 (cs) 1999-03-17
PT918759E (pt) 2003-01-31
DE69715009T2 (de) 2003-05-08
ES2180995T3 (es) 2003-02-16
FR2749583A1 (fr) 1997-12-12
WO1997047612A1 (fr) 1997-12-18
SK164598A3 (en) 1999-06-11
DK0918759T3 (da) 2002-11-25
EP0918759A1 (fr) 1999-06-02

Similar Documents

Publication Publication Date Title
AU726549B2 (en) New substituted 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them
JP3906935B2 (ja) Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
CA1328872C (en) Thiazolidinedione hypoglycemic agents
JP4790969B2 (ja) ペルオキシソーム増殖剤応答性受容体δの活性化剤
JPH08504199A (ja) 複素環誘導体および医薬におけるそれらの使用
KR20030097596A (ko) 치환된 티아졸리딘디온 유도체
HU217432B (hu) Eljárás tiazolidin-dion-származékok és az ezeket tartalmazó gyógyszerkészítmények előállítására, a vegyületek és a készítmények
EP0787727A1 (en) Benzoazine derivative or salt thereof and pharmaceutical composition comprising the same
EP0249407B1 (en) Antiallergy and antiinflammatory agents
KR960012206B1 (ko) 티아졸리딘-2,4-디온 유도체 및 이의 염, 이의 제조방법 및 이의 용도
JP4285723B2 (ja) 新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体
EP0398179B1 (en) Rhodanine derivatives and pharmaceutical compositions
WO2008035305A2 (en) Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia
JP2008528561A (ja) 新規な複素環式オキシム誘導体、それらの製造方法及び血糖降下剤又は脂質低下剤としてのそれらの使用
NZ534334A (en) New heterocyclic oxime compounds, a process for their preparation and pharmaceutical compositions containing them
US4880841A (en) Process of producing phenethylamine derivatives
US4889866A (en) Arylsulfonyl dihydropyridine derivatives
RU2208610C2 (ru) Пиперазиновые производные, способ их получения и содержащая их композиция
JP2948076B2 (ja) 新規チアゾリジンジオン化合物
JPWO2006126714A1 (ja) ペルオキシソーム増殖剤活性化受容体の活性化剤
NZ503471A (en) phenoxyalkyl alpha-halo acid derivatives and dialkyl esters of phenoxyalkyl derivatives
JPH08325250A (ja) 新規置換フェノール誘導体
JPH09169747A (ja) 新規置換フェニルチアゾリジン−２，４−ジオン誘導体及びその製造法
KR960008245B1 (ko) 로다닌 유도체 및 약제학적 조성물

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees